Even if you ignore FCF (on the call they said due to working capital), have look at EBIT on a quarterly basis, it was $372m this quarter and $489m last quarter.
Meanwhile costs are up from $286m in Dec quarter to $574m (!!) this quarter, driving by Stanwell rebates and other royalties. I was warned about their cost structure, but this was a lot worse than I had expected.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $268.2M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $641.5K | 4.084M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1324610 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 859272 | 10 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| CRN (ASX) Chart |